MOTS-c vs Thymosin Alpha 1

MOTS-c

MOTS-c is a 16-residue peptide encoded by a short open reading frame within the mitochondrial gene for 12S ribosomal RNA. It belongs to the mitochondrial-derived peptides, a small group that also includes humanin, which is encoded in the 16S rRNA gene. Since it was first described in the mid-2010s it has been studied mainly in cultured cells and in mice, with attention to glucose and lipid handling in skeletal muscle and to cellular responses to metabolic stress. Human data are limited and consist mostly of measurements of its circulating levels in observational studies.

Thymosin Alpha 1

Thymosin alpha 1 is a 28-residue peptide, acetylated at its N-terminus, first isolated from calf thymus extract and now made synthetically. It matches the N-terminal segment of a larger protein, prothymosin alpha, from which it is thought to be released by proteolytic processing; the synthetic form is also known as thymalfasin. The peptide is strongly acidic and, in water, largely unstructured. Its literature spans cell studies of immune signalling, animal infection and tumour models, and human clinical studies in chronic viral hepatitis, severe infection and vaccine response. Many of those clinical studies are small, and a defined cellular receptor has not been confirmed.

How MOTS-c acts

The first cell and mouse studies reported that MOTS-c inhibits the folate pathway and, with it, de novo purine synthesis, so that the purine intermediate AICAR accumulates. This nucleotide mimics AMP and activates AMP-activated protein kinase (AMPK), a sensor of cellular energy status. Later work reported that under metabolic or oxidative stress the peptide moves from the cytoplasm into the nucleus, where it associates with transcription factors including NRF2 and alters the expression of stress-response genes. Most of this mechanistic evidence comes from cell and rodent models, and human mechanistic data are scarce.

How Thymosin Alpha 1 acts

Thymosin alpha 1 has no single confirmed receptor. Several studies have linked its activity to Toll-like receptor signalling, particularly TLR9 and TLR2 in dendritic cells, with downstream activation of pathways including NF-κB and p38 MAPK. In cell and animal models it has been reported to influence T-cell maturation, production of cytokines such as interleukin-2 and interferon-gamma, and natural killer cell activity. Structural studies report that it becomes partly helical in membrane-like environments, which has been proposed as relevant to how it interacts with cells, though this remains an open question.

The records side by side

• Type: MOTS-c, Mitochondrial-derived peptide (MDP); Thymosin Alpha 1, Acetylated thymic peptide
• Length: MOTS-c, 16 amino acids; Thymosin Alpha 1, 28 amino acids
• Molecular weight: MOTS-c, 2174.6 g/mol; Thymosin Alpha 1, 3108.3 g/mol
• Molecular formula: MOTS-c, C101H152N28O22S2; Thymosin Alpha 1, C129H215N33O55

Reading a comparison

A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.